Dimensional Fund Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$99.6M Sell
305,563
-4,256
-1% -$1.39M 0.02% 1011
2025
Q1
$83.6M Sell
309,819
-23,842
-7% -$6.44M 0.02% 1121
2024
Q4
$78.5M Buy
333,661
+32,272
+11% +$7.59M 0.02% 1232
2024
Q3
$82.9M Buy
301,389
+35,183
+13% +$9.68M 0.02% 1177
2024
Q2
$64.7M Buy
266,206
+11,027
+4% +$2.68M 0.02% 1287
2024
Q1
$38.1M Sell
255,179
-11,855
-4% -$1.77M 0.01% 1648
2023
Q4
$51.1M Buy
267,034
+15,123
+6% +$2.9M 0.01% 1432
2023
Q3
$44.6M Buy
251,911
+10,921
+5% +$1.93M 0.01% 1422
2023
Q2
$45.8M Buy
240,990
+22,511
+10% +$4.28M 0.01% 1413
2023
Q1
$43.8M Buy
218,479
+23,903
+12% +$4.79M 0.01% 1430
2022
Q4
$46.2K Buy
194,576
+18,310
+10% +$4.35K 0.01% 1361
2022
Q3
$35.3M Buy
176,266
+2,841
+2% +$569K 0.01% 1473
2022
Q2
$25.3M Sell
173,425
-7,846
-4% -$1.14M 0.01% 1733
2022
Q1
$29.6M Buy
181,271
+2,111
+1% +$345K 0.01% 1756
2021
Q4
$30.4M Sell
179,160
-8,103
-4% -$1.37M 0.01% 1755
2021
Q3
$35.4M Sell
187,263
-17,736
-9% -$3.35M 0.01% 1673
2021
Q2
$34.7M Sell
204,999
-22,703
-10% -$3.85M 0.01% 1723
2021
Q1
$32.2M Sell
227,702
-7,299
-3% -$1.03M 0.01% 1756
2020
Q4
$30.5M Sell
235,001
-3,020
-1% -$393K 0.01% 1745
2020
Q3
$34.7M Sell
238,021
-8,309
-3% -$1.21M 0.01% 1482
2020
Q2
$36.5M Sell
246,330
-19,428
-7% -$2.88M 0.02% 1469
2020
Q1
$28.9M Buy
265,758
+4,513
+2% +$491K 0.02% 1498
2019
Q4
$30.1M Buy
261,245
+2,278
+0.9% +$262K 0.01% 1818
2019
Q3
$20.8M Buy
258,967
+7,709
+3% +$620K 0.01% 1985
2019
Q2
$18.2M Buy
251,258
+26,788
+12% +$1.94M 0.01% 2106
2019
Q1
$21M Sell
224,470
-678
-0.3% -$63.3K 0.01% 2026
2018
Q4
$16.4M Buy
225,148
+66,253
+42% +$4.83M 0.01% 2092
2018
Q3
$13.9M Sell
158,895
-3,047
-2% -$267K 0.01% 2296
2018
Q2
$15.9M Sell
161,942
-5,130
-3% -$505K 0.01% 2214
2018
Q1
$19.9M Sell
167,072
-6,685
-4% -$796K 0.01% 2064
2017
Q4
$22.1M Sell
173,757
-6,301
-3% -$801K 0.01% 2011
2017
Q3
$21.2M Buy
180,058
+629
+0.4% +$73.9K 0.01% 2017
2017
Q2
$14.3M Buy
179,429
+66,651
+59% +$5.32M 0.01% 2192
2017
Q1
$5.78M Buy
112,778
+1,428
+1% +$73.2K ﹤0.01% 2513
2016
Q4
$4.17M Buy
111,350
+695
+0.6% +$26K ﹤0.01% 2604
2016
Q3
$7.5M Buy
110,655
+9,086
+9% +$616K ﹤0.01% 2365
2016
Q2
$5.64M Sell
101,569
-861
-0.8% -$47.8K ﹤0.01% 2457
2016
Q1
$6.43M Buy
102,430
+2,852
+3% +$179K ﹤0.01% 2398
2015
Q4
$9.38M Sell
99,578
-21,738
-18% -$2.05M 0.01% 2249
2015
Q3
$9.75M Sell
121,316
-5,929
-5% -$476K 0.01% 2218
2015
Q2
$15.2M Buy
127,245
+2,042
+2% +$245K 0.01% 2044
2015
Q1
$13.1M Buy
125,203
+1,839
+1% +$192K 0.01% 2099
2014
Q4
$12M Sell
123,364
-28
-0% -$2.72K 0.01% 2140
2014
Q3
$9.64M Sell
123,392
-7,591
-6% -$593K 0.01% 2223
2014
Q2
$8.27M Sell
130,983
-91,339
-41% -$5.77M 0.01% 2333
2014
Q1
$14.9M Buy
222,322
+871
+0.4% +$58.5K 0.01% 1850
2013
Q4
$14.2M Sell
221,451
-5,702
-3% -$367K 0.01% 1870
2013
Q3
$14.5M Buy
227,153
+49,479
+28% +$3.17M 0.01% 1760
2013
Q2
$5.51M Buy
+177,674
New +$5.51M 0.01% 2440